As shown in our results, GSK3368715 treatment resulted in much smaller tumor volumes and tumor weights, and fewer Ki-67, meR206-PGK1, and pS203-PGK1 positive cells (Fig. 5K–N). This evidence concerns the gene PGK1 and neoplasm.